Back to top
more

McKesson (MCK)

(Delayed Data from NYSE)

$668.58 USD

668.58
1,298,850

+5.33 (0.80%)

Updated Aug 8, 2025 04:00 PM ET

After-Market: $667.86 -0.72 (-0.11%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 36% (89 out of 244)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Here's Why You Should Retain Intuitive Surgical (ISRG) Stock

by Zacks Equity Research

Intuitive Surgical (ISRG) continues to gain traction from the improving adoption of the da Vinci Surgical System. Higher production costs are a woe.

Zacks Equity Research

Quest Diagnostics (DGX) to Offer Lab Services for Lee Health

by Zacks Equity Research

Quest Diagnostics (DGX) inked a new agreement to deliver high-quality diagnostics services for a renowned healthcare provider in Southwest Florida.

Zacks Equity Research

Here's Why You Should Retain Boston Scientific (BSX) For Now

by Zacks Equity Research

Investors are optimistic about Boston Scientific's (BSX) impressive top-line results and notable acquisitions.

Zacks Equity Research

Inari Medical (NARI) Posts Positive Results of FLASH Registry

by Zacks Equity Research

Inari Medical's (NARI) FlowTriever's latest favorable results are expected to significantly improve the treatment of PE.

Zacks Equity Research

Neogen (NEOG) Launches Test for Detection of Cashew Allergen

by Zacks Equity Research

Neogen's (NEOG) new quantitative test shows a high level of specificity to very low levels of cashew protein (down to 0.2 ppm).

Zacks Equity Research

Exact Sciences (EXAS) Cologuard Business Grows Amid Cost Woes

by Zacks Equity Research

Following the acquisitions of Paradigm and Ashion, Exact Sciences (EXAS) is now offering therapy selection tests for patients with advanced cancer.

Zacks Equity Research

The Zacks Analyst Blog Highlights Corteva, Hershey, National Fuel Gas and McKesson

by Zacks Equity Research

Corteva, Hershey, National Fuel Gas and McKesson are included in this Analyst Blog.

Derek Lewis headshot

Defense Wins Ballgames; 3 Blue-Chip Stocks To Consider

by Derek Lewis

Due to their well-established nature and track records of success, these companies are positioned to weather a dark fiscal cloud better than most.

Zacks Equity Research

QIAGEN (QGEN) Assays to Detect Organ Transplant-Related Viruses

by Zacks Equity Research

QIAGEN's (QGEN) latest additions to the NeuMoDx assay menu will help identify EBV and HHV-6 viruses in immunocompromised patients.

Zacks Equity Research

3 Reasons to Hold QuidelOrtho (QDEL) Stock in Your Portfolio

by Zacks Equity Research

Investors continue to be optimistic about QuidelOrtho (QDEL) owing to its strong product portfolio.

Zacks Equity Research

Teleflex (TFX) Witnesses Lower UroLift Sales, Cost Woes

by Zacks Equity Research

Teleflex's (TFX) lowered revenue and adjusted EPS outlook for 2022 indicates lackluster performance, which increases investors' concern.

Zacks Equity Research

Abiomed's (ABMD) Impella-Related Research Gets FDA Clearance

by Zacks Equity Research

Abiomed's (ABMD) latest regulatory clearances for clinical research of Impella heart pumps in AMI cardiogenic shock patients are expected to significantly improve patient outcomes.

Zacks Equity Research

3 Reasons to Hold Catalent (CTLT) Stock in Your Portfolio

by Zacks Equity Research

Catalent's (CTLT) robust facility expansion activities and a slew of strategic deals raise optimism about the stock.

Snehadri Nag headshot

Beat the Market Vagaries With 4 Top-Ranked Defensive Bets

by Snehadri Nag

Grab these four defensive stocks, namely Corteva (CTVA), Hershey (HSY), National Fuel Gas Company (NFG) and McKesson (MCK), which hold strong potential.

Zacks Equity Research

Is SPDR Russell 1000 Momentum Focus ETF (ONEO) a Strong ETF Right Now?

by Zacks Equity Research

Smart Beta ETF report for ONEO

Zacks Equity Research

3 Reasons to Hold Insulet (PODD) Stock in Your Portfolio

by Zacks Equity Research

Investors continue to be optimistic about Insulet (PODD) on Omnipod's continued market access expansion.

Zacks Equity Research

Here's Why Investors Should Retain Integra (IART) Stock for Now

by Zacks Equity Research

Investors are optimistic about Integra's (IART) better-than-expected results and the continued demand for its products.

Zacks Equity Research

Tandem Diabetes (TNDM) Faces Expense Woes, Macro Issues

by Zacks Equity Research

Factoring in the pandemic and competitive pressure as well as evolving economic environment, including inflation and the threat of recession, Tandem Diabetes (TNDM) slashes full-year guidance.

Zacks Equity Research

Are Investors Undervaluing McKesson (MCK) Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

Zacks.com featured highlights include American Airlines, CVREnergy, Builders FirstSource, McKesson and Beacon Roofing Supply

by Zacks Equity Research

American Airlines, CVREnergy, Builders FirstSource, McKesson and Beacon Roofing Supply have been highlighted in this Screen of The Week article.

Zacks Equity Research

Zacks.com featured highlights Boise Cascade, Triton International, TotalEnergies, McKesson and RCI Hospitality Holdings

by Zacks Equity Research

Boise Cascade, Triton International, TotalEnergies, McKesson and RCI Hospitality Holdings have been highlighted in this Screen of The Week article.

Zacks Equity Research

LHC Group's (LHCG) Latest Tie-Up to Improve Patient Services

by Zacks Equity Research

LHC Group's (LHCG) latest JV is expected to expand the availability of vital healthcare services to patients in the comfort of their homes.

Zacks Equity Research

Here's Why Investors Should Retain Globus Medical (GMED) For Now

by Zacks Equity Research

Investors are optimistic about Globus Medical's (GMED) better-than-expected results and new product introductions.

Zacks Equity Research

Here's Why You Should Retain PerkinElmer (PKI) Stock Now

by Zacks Equity Research

PerkinElmer (PKI) continues to gain from solid product portfolio despite forex woes.

Zacks Equity Research

CVS Health (CVS) Progresses With Safe Medication Approach

by Zacks Equity Research

A major feature of CVS Health's (CVS) time delay safe function is that it cannot be overridden and is designed to deter pharmacy robbers.